Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ALAB vs MRNA✓SelectedUSD · MRNAALAB vs MRNA performance historyLatest closeAs of-2.62%11/13
Stock and ETF performance explorer

ALAB vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+257.6%
MRNA return
+116.0%
Excess return
+141.6%
Maximum drawdown
-63.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.6%-3.4%+0.8%-2.4%
7D+16.3%-12.1%+28.4%+17.1%
30D-26.1%-1.3%-24.8%-26.0%
3M-31.3%+250.9%-282.2%-37.3%
6M-1.0%+343.0%-344.0%-15.6%
YTD+33.3%+657.4%-624.1%-2.1%
1Y+53.5%+794.9%-741.4%+8.4%
All+257.6%+116.0%+141.6%+209.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling